TickerFacts.

Anika Therapeutics, Inc. (ANIK): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

14.34M
Year ended 2025-12-31
-1.0%
3-year compound annual growth
15.32M2009-12-31: 11.56M2010-12-31: 13.65M2011-12-31: 13.75M2012-12-31: 14.34M2013-12-31: 14.83M2014-12-31: 15.27M2015-12-31: 15.32M2016-12-31: 15.12M2017-12-31: 15.07M2018-12-31: 14.69M2019-12-31: 14.37M2020-12-31: 14.22M2021-12-31: 14.63M2022-12-31: 14.79M2023-12-31: 14.66M2024-12-31: 14.72M2025-12-31: 14.34M14.34M
2009-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3114.34M-2.6%2026-03-03, From 2025-01-01
2024-12-3114.72M+0.4%2026-03-03, From 2024-01-01
2023-12-3114.66M-0.9%2026-03-03, From 2023-01-01
2022-12-3114.79Mn/c2025-03-17, From 2022-01-01
2021-12-3114.63M+2.9%2024-03-15, From 2021-01-01
2020-12-3114.22M-1.1%2023-03-16, From 2020-01-01
2019-12-3114.37M-2.1%2022-03-11, From 2019-01-01
2018-12-3114.69M-2.5%2021-04-26, From 2018-01-01
2017-12-3115.07M-0.3%2020-03-06, From 2017-01-01
2016-12-3115.12M-1.3%2019-02-27, From 2016-01-01
2015-12-3115.32M+0.3%2018-02-27, From 2015-01-01
2014-12-3115.27M+3.0%2017-02-24, From 2014-01-01
2013-12-3114.83M+3.4%2016-03-10, From 2013-01-01
2012-12-3114.34M+4.3%2015-03-13, From 2012-01-01
2011-12-3113.75M+0.7%2014-03-13, From 2011-01-01
2010-12-3113.65M+18.0%2013-03-14, From 2010-01-01
2009-12-3111.56Mn/a2012-03-13, From 2009-01-01